Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

4.

The intestine as a regulator of cholesterol homeostasis in diabetes.

Tomkin GH.

Atheroscler Suppl. 2008 Sep;9(2):27-32. doi: 10.1016/j.atherosclerosissup.2008.05.012. Review.

PMID:
18693145
5.

The role of dietary cholesterol in the regulation of postprandial apolipoprotein B48 levels in diabetes.

Taggart C, Gibney J, Owens D, Collins P, Johnson A, Tomkin GH.

Diabet Med. 1997 Dec;14(12):1051-8.

PMID:
9455933
6.

Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?

Battula SB, Fitzsimons O, Moreno S, Owens D, Collins P, Johnson A, Tomkin GH.

Metabolism. 2000 Aug;49(8):1049-54.

PMID:
10954025
7.

Dyslipidaemia--hepatic and intestinal cross-talk.

Tomkin GH.

Atheroscler Suppl. 2010 Jun;11(1):5-9. doi: 10.1016/j.atherosclerosissup.2010.03.005. Review.

PMID:
20434963
8.

Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima Fatty rats.

Qin B, Anderson RA, Kuzuya T, Kitaura Y, Shimomura Y.

Atherosclerosis. 2012 Jun;222(2):409-16. doi: 10.1016/j.atherosclerosis.2012.03.033.

PMID:
22546076
10.

Lipoprotein alterations in 10- and 20-week-old Zucker diabetic fatty rats: hyperinsulinemic versus insulinopenic hyperglycemia.

Sparks JD, Phung TL, Bolognino M, Cianci J, Khurana R, Peterson RG, Sowden MP, Corsetti JP, Sparks CE.

Metabolism. 1998 Nov;47(11):1315-24.

PMID:
9826206
11.

Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes.

Phillips C, Bennett A, Anderton K, Owens D, Collins P, White D, Tomkin GH.

Metabolism. 2002 Jul;51(7):847-52.

PMID:
12077729
12.

Effects of pioglitazone on stearoyl-CoA desaturase in obese Zucker fa/fa rats.

Toyama T, Kudo N, Hibino Y, Mitsumoto A, Nishikawa M, Kawashima Y.

J Pharmacol Sci. 2007 Jun;104(2):137-45.

14.

Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study.

Chappuis B, Braun M, Stettler C, Allemann S, Diem P, Lumb PJ, Wierzbicki AS, James R, Christ ER.

Diabetes Metab Res Rev. 2007 Jul;23(5):392-9.

PMID:
17211855
15.

Intestinal and hepatic cholesterol carriers in diabetic Psammomys obesus.

Levy E, Lalonde G, Delvin E, Elchebly M, Précourt LP, Seidah NG, Spahis S, Rabasa-Lhoret R, Ziv E.

Endocrinology. 2010 Mar;151(3):958-70. doi: 10.1210/en.2009-0866.

PMID:
20130116
16.

Dyslipidaemia of diabetes and the intestine.

Tomkin GH, Owens D.

World J Diabetes. 2015 Jul 10;6(7):970-7. doi: 10.4239/wjd.v6.i7.970. Review.

17.

Insulin sensitization in diabetic rat liver by an antihyperglycemic agent.

Hofmann C, Lorenz K, Williams D, Palazuk BJ, Colca JR.

Metabolism. 1995 Mar;44(3):384-9.

PMID:
7885286
18.

Polyphenol-rich black chokeberry (Aronia melanocarpa) extract regulates the expression of genes critical for intestinal cholesterol flux in Caco-2 cells.

Kim B, Park Y, Wegner CJ, Bolling BW, Lee J.

J Nutr Biochem. 2013 Sep;24(9):1564-70. doi: 10.1016/j.jnutbio.2013.01.005.

PMID:
23517916
19.
20.

VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: effects of dietary fructose alone or in combination with pioglitazone.

Kaumi T, Hirano T, Odaka H, Ebara T, Amano N, Hozumi T, Ishida Y, Yoshino G.

Diabetes. 1996 Jun;45(6):806-11.

PMID:
8635657
Items per page

Supplemental Content

Support Center